Facebook and Movado Downgraded, Deutsche Initiates Drugmakers

Now watching

Next video starts in : 7 Play

Facebook and Movado Downgraded, Deutsche Initiates Drugmakers

Facebook and Movado Downgraded, Deutsche Initiates Drugmakers
Replay video
Up next

July Fourth in New York City Means Two Things: Fireworks and Hot Dog Eating Contests

Unlock your personal NFL Now stream by signing in to NFL.com

Facebook and Movado Downgraded, Deutsche Initiates Drugmakers

by TheStreet 0:49 mins

In Tuesday's Analysts' Actions, top downgrades include Facebook and Movado while Deutsche Bank initiates pharmaceutical companies. Facebook (FB) is now rated a 'Neutral', down from 'Buy' at Janney Montgomery Scott. The firm says the social media company is facing valuation headwinds in 2015. The price target of $82.50 a share remains. Deutsche Bank is now covering the drug making sector. The firm is starting Pfizer (PFE) and Eli Lily (LLY) with 'Buy' ratings. But Deutsche Bank is starting coverage of Bristol-Myers Squibb (BMY) and Merck (MRK) with 'Hold' ratings. High-end watchmaker Movado (MOV) was downgraded to 'Equal Weight' from 'Overweight' at Stephens. The analyst there also lowered the price target to $44 from $52 a share citing decreased visibility on Movado's sales in second half of the year.

View Comments (0)